NASDAQ
NeuBase Therapeutics, Inc. (NBSE) has a eps (basic) of $-21.08 as of Friday, September 30, 2022. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.